메뉴 건너뛰기




Volumn 9, Issue 1, 2011, Pages 57-64

The role of osteoprotegrin/nuclear factor kB ligand in coronary collateral development

Author keywords

CAD; Collateralization; Osteoprotegrin; RANKL

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGRIN; PROTEGRIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

EID: 81755169077     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1100900109     Document Type: Article
Times cited : (9)

References (28)
  • 1
    • 0035205181 scopus 로고    scopus 로고
    • Frequency distribution of collateral flow and factors influencing collateral channel development: Functional collateral channel measurement in 450 patients with coronary artery disease
    • DOI 10.1016/S0735-1097(01)01675-8, PII S0735109701016758
    • Pohl T, Seiler C, Billinger M, et al. Frequency distribution of collateral flow and actors influencing collateral channel development: functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001; 38:1872-78. (Pubitemid 33116557)
    • (2001) Journal of the American College of Cardiology , vol.38 , Issue.7 , pp. 1872-1878
    • Pohl, T.1    Seiler, C.2    Billinger, M.3    Herren, E.4    Wustmann, K.5    Mehta, H.6    Windecker, S.7    Eberli, F.R.8    Meier, B.9
  • 2
    • 12344288420 scopus 로고    scopus 로고
    • Growth factor-induced therapeutic angiogenesis in the heart: Protein therapy
    • DOI 10.1016/j.cardiores.2004.09.004, PII S000863630400389X
    • Annex BH, Simons M. Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. Cardiovasc Res 2005; 65:649-55. (Pubitemid 40138985)
    • (2005) Cardiovascular Research , vol.65 , Issue.3 , pp. 649-655
    • Annex, B.H.1    Simons, M.2
  • 3
    • 9344246863 scopus 로고    scopus 로고
    • Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
    • DOI 10.1161/01.RES.0000149165.99974.12
    • Collin-Osdoby P. Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin. Circ Res 2004; 95:1046-57. (Pubitemid 39557891)
    • (2004) Circulation Research , vol.95 , Issue.11 , pp. 1046-1057
    • Collin-Osdoby, P.1
  • 5
    • 61449157230 scopus 로고    scopus 로고
    • Marta Scatena. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function
    • McGonigle JS, Giachelli CM. Marta Scatena. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. Angiogenesis 2009; 12:35-46.
    • (2009) Angiogenesis , vol.12 , pp. 35-46
    • McGonigle, J.S.1    Giachelli, C.M.2
  • 8
    • 0032584208 scopus 로고    scopus 로고
    • Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
    • Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95:3597-02.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 3597-3602
    • Yasuda, H.1    Shima, N.2    Nakagawa, N.3
  • 9
    • 0034817070 scopus 로고    scopus 로고
    • Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
    • DOI 10.1006/bbrc.2000.4130
    • Hofbauer LC, Shui C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brien T, Khosla S. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001; 280:334-39. (Pubitemid 32917516)
    • (2001) Biochemical and Biophysical Research Communications , vol.280 , Issue.1 , pp. 334-339
    • Hofbauer, L.C.1    Shui, C.2    Riggs, B.L.3    Dunstan, C.R.4    Spelsberg, T.C.5    O'Brien, T.6    Khosla, S.7
  • 10
    • 0035094860 scopus 로고    scopus 로고
    • Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women
    • DOI 10.1210/jc.86.2.631
    • Browner WS, Lui LY, Cummings SR. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 2001; 86:631-37. (Pubitemid 32207471)
    • (2001) Journal of Clinical Endocrinology and Metabolism , vol.86 , Issue.2 , pp. 631-637
    • Browner, W.S.1    Lui, L.-Y.2    Cummings, S.R.3
  • 13
    • 53649085238 scopus 로고    scopus 로고
    • Role of alpha(v) integrin in osteoprotegerin-induced endothelial cell migration and proliferation
    • Kobayashi-Sakamoto M, Isogai E, Hirose K, Chiba I. Role of alpha(v) integrin in osteoprotegerin-induced endothelial cell migration and proliferation. Microvasc Res 2008; 76:139-44.
    • (2008) Microvasc Res , vol.76 , pp. 139-144
    • Kobayashi-Sakamoto, M.1    Isogai, E.2    Hirose, K.3    Chiba, I.4
  • 15
    • 0037015255 scopus 로고    scopus 로고
    • Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease
    • DOI 10.1161/01.CIR.0000031524.49139.29
    • Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002; 106:1192-94. (Pubitemid 34988634)
    • (2002) Circulation , vol.106 , Issue.10 , pp. 1192-1194
    • Jono, S.1    Ikari, Y.2    Shioi, A.3    Mori, K.4    Miki, T.5    Hara, K.6    Nishizawa, Y.7
  • 17
    • 33645820419 scopus 로고    scopus 로고
    • Circulating osteoprotegrin and soluble RANKL: Do they have a future in clinical practice?
    • Dovio A, Data V, Angeli A. Circulating osteoprotegrin and soluble RANKL: do they have a future in clinical practice? J Endocrinol Invest 2005; 28:14-22.
    • (2005) J Endocrinol Invest , vol.28 , pp. 14-22
    • Dovio, A.1    Data, V.2    Angeli, A.3
  • 18
    • 67349099856 scopus 로고    scopus 로고
    • Osteoprotegerin, vascular calcification and atherosclerosis
    • Campenhout AV, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 2009; 204:321-29.
    • (2009) Atherosclerosis , vol.204 , pp. 321-329
    • Campenhout, A.V.1    Golledge, J.2
  • 19
    • 42349105256 scopus 로고    scopus 로고
    • Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions
    • Kinnaird T, Stabile E, Zbinden S, Burnett M, Epstein SE. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovascular Research 2008; 78:257-64.
    • (2008) Cardiovascular Research , vol.78 , pp. 257-264
    • Kinnaird, T.1    Stabile, E.2    Zbinden, S.3    Burnett, M.4    Epstein, S.E.5
  • 20
    • 0021923120 scopus 로고
    • Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects
    • Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587-92. (Pubitemid 15141963)
    • (1985) Journal of the American College of Cardiology , vol.5 , Issue.3 , pp. 587-592
    • Rentrop, K.P.1    Cohen, M.2    Blanke, H.3    Phillips, R.A.4
  • 27
    • 38349133382 scopus 로고    scopus 로고
    • Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice
    • Morony S, Tintut Y, Zhang Z, et al. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation 2008; 117:411-20.
    • (2008) Circulation , vol.117 , pp. 411-420
    • Morony, S.1    Tintut, Y.2    Zhang, Z.3
  • 28
    • 33645221176 scopus 로고    scopus 로고
    • Osteoprotegerin (OPG):a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?
    • Cross SS, Yang Z, Brown NJ, et al. Osteoprotegerin (OPG):a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis? Int J Cancer 2006; 118:1901-8.
    • (2006) Int J Cancer , vol.118 , pp. 1901-1908
    • Cross, S.S.1    Yang, Z.2    Brown, N.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.